Injection paradigm for administration of botulinum toxins | Patent Publication Number 20190060423
US 20190060423 A1Patent NumberUS 10729751 B2
Application Number16173664
Filled DateOct 29, 2018
Priority DateMar 13, 2015
Publication DateFeb 28, 2019
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsMitchell F. Brin
Andrew M. Blumenfeld
Andrew M. Blumenfeld
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.